Literature DB >> 17076454

Challenges to military working dog management and care in the Kuwait theater of operation.

Caroline A Toffoli1, David S Rolfe.   

Abstract

In a combat environment, troop safety and installation security are paramount. Documentation of the frequent use of explosive devices by insurgents in Southwest Asia has increased the need for augmentation of defensive capabilities. Military working dogs (MWDs) are trained and certified to perform missions supporting security and detection of explosives. Challenges arise in theater because the number of certified dogs available can be limited and the standards of housing and care that are available in the continental United States are not usually available in a combat theater. Planning, preparation, and training of MWD handlers,animal care specialists, and Veterinary Corps officers will maximize mission performance and MWD health. Some of th echallenges and needs associated with management and care of the MWDs in the Kuwait theater of operation are discussed. Suggested improvements to the current deployment readiness paradigm are offered from the perspective of a staff veterinarian who was deployed in support of Operation Iraqi Freedom in 2004.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17076454     DOI: 10.7205/milmed.171.10.1002

Source DB:  PubMed          Journal:  Mil Med        ISSN: 0026-4075            Impact factor:   1.437


  2 in total

1.  A Systematic Review of the Reliability and Validity of Behavioural Tests Used to Assess Behavioural Characteristics Important in Working Dogs.

Authors:  Karen Brady; Nina Cracknell; Helen Zulch; Daniel Simon Mills
Journal:  Front Vet Sci       Date:  2018-05-25

2.  Military Working Dogs Operating in Afghanistan Theater: Comparison between Pre- and Post-Mission Blood Analyses to Monitor Physical Fitness and Training.

Authors:  Giuseppe Spinella; Lorenzo Tidu; Lisa Grassato; Vincenzo Musella; Micheletino Matarazzo; Simona Valentini
Journal:  Animals (Basel)       Date:  2022-03-01       Impact factor: 2.752

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.